Literature DB >> 1936597

Activation by vanadate of glycolysis in hepatocytes from diabetic rats.

J E Rodríguez-Gil1, A M Gómez-Foix, C Fillat, F Bosch, J J Guinovart.   

Abstract

In hepatocytes from starved streptozocin-induced diabetic rats, vanadate increases the glycolytic flux because it raises the levels of fructose-2,6-bisphosphate (Fru-2,6-P2), the main regulatory metabolite of this pathway. This effect of vanadate on Fru-2,6-P2 levels is time and dose dependent, and it remains in cells incubated in a calcium-depleted medium. Vanadate is also able to counteract the decrease on Fru-2,6-P2 levels produced by glucagon, colforsin, or exogenous cAMP. However, vanadate does not modify 6-phosphofructo-2-kinase and pyruvate kinase activities, but it does counteract the inactivation of these enzymes induced by glucagon. Likewise, Fru-2,6-P2ase activity is also not affected by vanadate. In addition, vanadate is able to increase the production of both lactate and CO2 in hepatocytes from streptozocin-induced diabetic rats incubated in the presence of glucose in the medium. Vanadate behaves as a glycolytic effector in these cells, and this effect may be related to its ability to normalize blood glucose levels in diabetic animals.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1936597     DOI: 10.2337/diab.40.10.1355

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  8 in total

1.  In vivo effects of vanadate on hepatic glycogen metabolizing and lipogenic enzymes in insulin-dependent and insulin-resistant diabetic animals.

Authors:  R L Khandelwal; S Pugazhenthi
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

2.  Long-term correction of STZ-diabetic rats after short-term i.p. VOSO4 treatment: persistence of insulin secreting capacities assessed by isolated pancreas studies.

Authors:  P Poucheret; R Gross; A Cadène; M Mantéguetti; J J Serrano; G Ribes; G Cros
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

3.  Screening Protein Prognostic Biomarkers for Stomach Adenocarcinoma Based on The Cancer Proteome Atlas.

Authors:  Guo-Liang Zheng; Guo-Jun Zhang; Yan Zhao; Zhi-Chao Zheng
Journal:  Front Oncol       Date:  2022-04-28       Impact factor: 5.738

4.  Vanadate treatment restores the expression of genes for key enzymes in the glucose and ketone bodies metabolism in the liver of diabetic rats.

Authors:  A Valera; J E Rodriguez-Gil; F Bosch
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

5.  Non-insulin-like action of sodium orthovanadate in the isolated perfused liver of fed, non-diabetic rats.

Authors:  M Roden; K Liener; C Fürnsinn; M Prskavec; P Nowotny; I Steffan; H Vierhapper; W Waldhäusl
Journal:  Diabetologia       Date:  1993-07       Impact factor: 10.122

6.  Effects of three and eight weeks oral administration of bis(maltolato)oxovanadium(IV) on plasma homocysteine and cysteine levels in streptozotocin-induced diabetic rats.

Authors:  Kishor M Wasan; Verica Risovic; Violet G Yuen; Alan Hicke; John H McNeill
Journal:  Exp Clin Cardiol       Date:  2004

7.  Molybdate and tungstate act like vanadate on glucose metabolism in isolated hepatocytes.

Authors:  C Fillat; J E Rodríguez-Gil; J J Guinovart
Journal:  Biochem J       Date:  1992-03-15       Impact factor: 3.857

Review 8.  Structure, regulation, and biological functions of TIGAR and its role in diseases.

Authors:  Jie Tang; Lei Chen; Zheng-Hong Qin; Rui Sheng
Journal:  Acta Pharmacol Sin       Date:  2021-01-28       Impact factor: 7.169

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.